BioLife Solutions, Inc.
BLFS
$25.41
-$1.09-4.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 10.41% | 6.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.41% | 6.18% | |||
| Cost of Revenue | 12.88% | 10.21% | |||
| Gross Profit | 9.05% | 4.10% | |||
| SG&A Expenses | 3.36% | 0.21% | |||
| Depreciation & Amortization | -1.27% | 0.85% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.08% | 5.50% | |||
| Operating Income | 92.07% | 7.88% | |||
| Income Before Tax | 104.47% | -3,520.28% | |||
| Income Tax Expenses | -34.92% | 800.00% | |||
| Earnings from Continuing Operations | 103.92% | -3,435.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 103.92% | -3,435.27% | |||
| EBIT | 92.07% | 7.88% | |||
| EBITDA | 379.23% | 56.63% | |||
| EPS Basic | 103.92% | -3,388.42% | |||
| Normalized Basic EPS | 468.00% | 56.90% | |||
| EPS Diluted | 103.02% | -3,388.42% | |||
| Normalized Diluted EPS | 460.00% | 56.90% | |||
| Average Basic Shares Outstanding | 0.27% | 1.41% | |||
| Average Diluted Shares Outstanding | 1.94% | 1.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||